StockStory.org on MSN
PacBio (NASDAQ:PACB) misses Q1 CY2026 sales expectations
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q1 CY2026, with sales flat year on year at $37.18 million ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) is among the 12 Best Genomics Stocks to Invest In. On December 15, TheFly published that Luke Sergott, a Barclays analyst, lifted the price ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results